| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/13/2005 | WO2005002556A1 Use of osmolytes obtained from extremophilic bacteria for the production of inhalable medicaments for the prophylaxis and treatment of pulmonary and cardiovascular diseases and an inhalation device comprising an osmolyte as active agent component |
| 01/13/2005 | WO2005002554A2 A method of promoting sleep using topical administration of vasoactive agents |
| 01/13/2005 | WO2005002553A2 Fluconazole capsules with improved release |
| 01/13/2005 | WO2005002550A1 Nanoparticles of polyoxyethylenated derivatives |
| 01/13/2005 | WO2005002549A1 Parathyroid hormone (pth) containing pharmaceutical compositions for oral use |
| 01/13/2005 | WO2005002548A1 Stable pharmaceutical compositions of 2-aza-bicyclo[3.3.0]-octane-3-carboxylic acid derivatives |
| 01/13/2005 | WO2005002547A1 Matrix adjuvants and the drop pills prepared with them |
| 01/13/2005 | WO2005002546A1 Stabilized topotecan liposomal composition and methods |
| 01/13/2005 | WO2005002544A2 Stabilized particle dispersions containing nanoparticles |
| 01/13/2005 | WO2005002543A1 Composition and method for the treatment of water related ear disorders |
| 01/13/2005 | WO2005002542A2 Nanoparticulate meloxican formulations |
| 01/13/2005 | WO2005002541A2 Process for preparing formulations of lipid-regulating drugs |
| 01/13/2005 | WO2005002540A2 Dry powder pharmaceutical suspension compositions of cefuroxime axetil |
| 01/13/2005 | WO2005002510A2 Deployable multifunctional hemostatic agent |
| 01/13/2005 | WO2005002482A1 Transdermal hormone delivery system: compositions and methods |
| 01/13/2005 | WO2004098567A3 Tamper-resistant transdermal dosage form comprising an active agent component and an adverse agent component at the distal site of the active agent layer |
| 01/13/2005 | WO2004096175A3 Taste masked microcapsules and processes for their preparation |
| 01/13/2005 | WO2004091633A8 Pharmaceutical compositions for intranasal administration of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.o]non-1 (7)-en-2-yl)alkyl] phosphonic acid and derivatives and methods of use thereof |
| 01/13/2005 | WO2004087097A3 Stable liposomes or micelles comprising a sphinolipid and a peg-lipopolymer |
| 01/13/2005 | WO2004075933A3 Devices for releasing volatile substances and methods of producing the devices |
| 01/13/2005 | WO2004073654A3 A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained supression of gastric acid |
| 01/13/2005 | WO2004073582A3 Pearlescent film coating systems and substrates coated therewith |
| 01/13/2005 | WO2004045633A3 Pharmaceutical composition comprising octreotide microparticles |
| 01/13/2005 | WO2004006958A8 Stable pharmaceutical composition comprising erythropoietin |
| 01/13/2005 | WO2003070156A3 Orally administrable pharmaceutical formulation comprising ephedrine hydrochloride and process for preparing the same |
| 01/13/2005 | US20050010269 Microprocessor controlled ambulatory medical apparatus with hand held communication device |
| 01/13/2005 | US20050010196 Osmotic delivery system and method for decreasing start-up times for osmotic delivery systems |
| 01/13/2005 | US20050010166 Apparatus for drug delivery in association with medical or surgical procedures |
| 01/13/2005 | US20050010165 Method for drug delivery in association with medical or surgical procedures |
| 01/13/2005 | US20050010036 Peptide marker targeting to nasopharyngeal carcinoma cell and application thereof |
| 01/13/2005 | US20050009931 Dispersible pharmaceutical composition for treatment of mastitis and otic disorders |
| 01/13/2005 | US20050009923 Bronchodilating beta-agonist compositions and methods |
| 01/13/2005 | US20050009921 Compounds having aromatic rings and side-chain amide-functionality and a method for transporting monovalent anions across biological membranes using the same |
| 01/13/2005 | US20050009910 Delivery of an active drug to the posterior part of the eye via subconjunctival or periocular delivery of a prodrug |
| 01/13/2005 | US20050009908 Aqueous dispersion comprising stable nonoparticles of a water-insoluble active and an excipient like middle chain triglycerides (mct) |
| 01/13/2005 | US20050009902 Treating any types of pruritus such as ocular pruritus, skin pruritus and systemic pruritus with a cannabinoid agonist such as palmidrol and anandamide or a derivative |
| 01/13/2005 | US20050009857 Powder formulations containing tiotropium suitable for inhalation |
| 01/13/2005 | US20050009813 Use of desoxypeganine for treating clinical depression |
| 01/13/2005 | US20050009811 Saquinavir mesylate oral dosage form |
| 01/13/2005 | US20050009806 Comprises angiotensin converting enzyme (ACE) inhibitors such as quinapril; improved shelf-life/storage stability |
| 01/13/2005 | US20050009800 Solid, free-flowing dry extract of a natural mixture of conjugated equine estrogens that has been applied by spraying an aqueous solution of the mixture onto a powdered or granular microcrystalline cellulose support that may contain lactose |
| 01/13/2005 | US20050009795 Mixtures or organic compounds for the treatment of airway diseases |
| 01/13/2005 | US20050009793 Treatment of liver disease with active vitamin D compounds |
| 01/13/2005 | US20050009791 Especially lysine, arginine, histidine, omithine and diaminobutyric acid; improved solubility for parenteral administration |
| 01/13/2005 | US20050009787 Complex of phosphate and ubiquinone, ascorbic acid, retinol, tocotriennol in mixture with carrier |
| 01/13/2005 | US20050009778 Method for treating retinal degeneration with purinergic receptor agonists |
| 01/13/2005 | US20050009752 Novel peptides and medicinal uses thereof |
| 01/13/2005 | US20050009739 Formulation strategies in stabilizing peptides in organic solvents and in dried states |
| 01/13/2005 | US20050009735 Aqueous solution of insulin and surfactant; storage stability |
| 01/13/2005 | US20050009731 Propofol formulations with non-reactive container closures |
| 01/13/2005 | US20050009025 A soluble T cell receptor for use as diagnostic indicator of infection and autoimmune diseases |
| 01/13/2005 | US20050008763 Antimicrobial coatings for medical applications |
| 01/13/2005 | US20050008746 Colorant for food and pharmaceuticals |
| 01/13/2005 | US20050008735 Base medium formed from polymer, delivery unit being orally soluble such that it disintegrates relatively slowly when placed on the roof of a human mouth and licked, containing flavoring and dosage of desired delivery substance |
| 01/13/2005 | US20050008730 Tablet press machine |
| 01/13/2005 | US20050008707 Nanoparticulate megestrol formulations |
| 01/13/2005 | US20050008706 Controlled agglomeration |
| 01/13/2005 | US20050008704 Mixture of drug and polyoxyethylene glycol; high speed dissolving |
| 01/13/2005 | US20050008703 Medical formulation containing a muscarinic agonist |
| 01/13/2005 | US20050008702 Rupturing controlled release device having a preformed passageway |
| 01/13/2005 | US20050008701 Formulation and process for drug loaded cores |
| 01/13/2005 | US20050008700 Control release; module with biocompatibile polymer matrix ; cylinder shape |
| 01/13/2005 | US20050008699 Effervescent glucosamine composition |
| 01/13/2005 | US20050008698 Base material for dry direct tableting comprising low-substituted hydroxypropyl cellulose |
| 01/13/2005 | US20050008697 Oral solid solution formulation of a poorly water-soluble active substance |
| 01/13/2005 | US20050008696 Using compression, thermal cycle molding, and thermal setting molding modules in continuous process |
| 01/13/2005 | US20050008694 Vaginally administratable progesterone-containing tablets and method for preparing same |
| 01/13/2005 | US20050008693 Process for the preparation of directly compressible alpha-mannitol |
| 01/13/2005 | US20050008692 Compositions comprising pectin and ascorbic acid |
| 01/13/2005 | US20050008691 Bicalutamide compositions |
| 01/13/2005 | US20050008690 Multi-phase, multi-compartment capsular delivery apparatus and methods for using same |
| 01/13/2005 | US20050008689 High efficiency encapsulation of charged therapeutic agents in lipid vesicles |
| 01/13/2005 | US20050008688 Oral administering; tablet with enteric coating; supplying drug to gastrointestinal systems |
| 01/13/2005 | US20050008687 Antioxidant; anticancer agents |
| 01/13/2005 | US20050008686 Cochleate preparations of fragile nutrients |
| 01/13/2005 | US20050008685 Mixture containing liposome electrolytes |
| 01/13/2005 | US20050008678 Solid foods; creatine suspended in support matrix |
| 01/13/2005 | US20050008673 Elongated member containing drug in biodegradable material |
| 01/13/2005 | US20050008664 Leukemia therapy; anticancer agents |
| 01/13/2005 | US20050008662 Use of IV emulsions with different triglyceride composition, particle size and apolipoprotein E for targeted tissue delivery of hydrophobic compounds |
| 01/13/2005 | US20050008661 Mixture of polymer in solvent; drug delivery; storage stability |
| 01/13/2005 | US20050008657 Cutting tree; aeration; purification |
| 01/13/2005 | US20050008634 Parenteral formulations of peptides for the treatment of systemic lupus erythematosus |
| 01/13/2005 | US20050008614 Herpes virus; papillomas virus; skin; urogenital systems; topical applying; spray dressing |
| 01/13/2005 | US20050008613 Immobilized on solid carrier; reducing concentration of microbiocides; water purification; foods |
| 01/13/2005 | US20050008610 Vascular site in mammals |
| 01/13/2005 | US20050008609 Multi-component reverse thermo-sensitive polymeric systems |
| 01/13/2005 | US20050008581 Methods and compositions that enhance bioavailability of coenzyme-Q10 |
| 01/13/2005 | US20050008580 Hemophilia treatment by inhalation of coagulation factors |
| 01/13/2005 | US20050008578 HFC solution formulations containing an anticholinergic |
| 01/13/2005 | US20050008572 Biocompatibility; sustained release |
| 01/13/2005 | US20050008569 Contract agent for imaging; ultrasonic , magnetic resonance imaging, computer temography; gadolinum, or compound thereof, encapsulated in shell; cancer therapy |
| 01/13/2005 | US20050008557 Surface treatment; prewashing, stabilization; heating |
| 01/13/2005 | US20050006401 Gas generating device and use of the device in continuous liquid supply |
| 01/13/2005 | DE4423078B4 Verfahren zur Herstellung einer Carbamazepin-Arzneiform mit verzögerter Wirkstofffreisetzung A process for the preparation of a carbamazepine pharmaceutical form with delayed release of active ingredient |
| 01/13/2005 | DE10328666A1 Tabletten enthaltend Geschmacks-und/oder Aromastoffe Tablets containing flavoring and / or aromatic substances |
| 01/13/2005 | CA2734055A1 Modified fluorinated nucleoside analogues |
| 01/13/2005 | CA2734052A1 Modified fluorinated nucleoside analogues |
| 01/13/2005 | CA2533312A1 Transdermal hormone delivery system: compositions and methods |
| 01/13/2005 | CA2531136A1 Parathyroid hormone (pth) containing pharmaceutical compositions for oral use |